Prostate cancer screening with PSA: "Aequanimitas"

Prostate cancer screening with PSA: "Aequanimitas"

Bibliographic Details
Main Author:	Marcus V. Sadi Dr.
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2013-07-01
Series:	International Brazilian Journal of Urology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382013000400447&lng=en&tlng=en

Similar Items

Editorial: Aequanimitas
by: Jesús J. de la Gándara Martín
Published: (2021-12-01)

Art, science, and aequanimitas: Pillars of modern anesthesia practice
by: Ameya Karanjkar, et al.
Published: (2020-01-01)

Prostate cancer: estimating the benefits of PSA screening.
by: Vickers, A, et al.
Published: (2009)

Metastatic prostate cancer in the modern era of PSA screening
by: Philip A. Fontenot Jr, et al.

Prostate cancer screening with PSA: new data, old debate
by: Stefania Sciallero, et al.
Published: (2011-12-01)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
by: Naseruddin Höti, et al.
Published: (2023-02-01)

Impact of numeracy on understanding of prostate cancer risk reduction in PSA screening.
by: Kevin Koo, et al.
Published: (2017-01-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
by: Amit M. Algotar PhD, MBBS, et al.
Published: (2011-05-01)

Finding the PSA-based screening stopping age using prostate cancer risk
by: Azin Nahvijou, et al.
Published: (2024-01-01)

Dynamics of Medical Screening: A Simulation Model of PSA Screening for Early Detection of Prostate Cancer
by: Özge Karanfil
Published: (2023-05-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)

Evaluation of a rapid one-step PSA test for primary prostate cancer screening
by: Shingo Ashida, et al.
Published: (2021-09-01)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
by: Strittmatter F, et al.
Published: (2011-10-01)

Prostate Cancer Screening with PSA: Ten Years’ Experience of Population Based Early Prostate Cancer Detection Programme in Lithuania
by: Ausvydas Patasius, et al.
Published: (2020-11-01)

Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial
by: Urban Emmenegger, et al.
Published: (2022-11-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening
by: Ridwan Alam, et al.
Published: (2017-02-01)

Contribution of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP) to the ongoing debate on the value of prostate cancer screening
by: Martin, RM, et al.
Published: (2022)

Controversies in PSA screening
by: O'Sullivan, J
Published: (2017)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
by: Hyungseok Cho, et al.
Published: (2022-03-01)

Diagnostic value of free-to-total PSA proportion and PSA density in prostate cancer detection for prostate volumes >= 100 cc
by: Murat Zor, et al.
Published: (2018-12-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
by: Tsung-Hsin Chang, et al.
Published: (2020-10-01)

PSA testing for men at average risk of prostate cancer
by: Bruce K Armstrong, et al.
Published: (2017-07-01)

The importance of PSA-Density in active surveillance for prostate cancer
by: Caner Ediz, et al.
Published: (2020-06-01)

Autopsy prostate cancer: Pre and post PSA era
by: R Kumar, et al.
Published: (2006-01-01)

Predictors of Clinically Significant Prostate Cancer: A Comparative Study of PSA, PSA Density, and MRI Parameters
by: Mehmet Coşkun, et al.
Published: (2021-02-01)

AGE, TOTAL PSA, PSA DENSITY AND GLEASON SCORE, TAUS AS PREDICTIVE FACTORS IN PATIENTS WITH PROSTATE CANCER
by: Daruqutni Albar, et al.
Published: (2016-03-01)

Comparison between PSA density, free PSA percentage and PSA density in the transition zone in the detection of prostate cancer in patients with serum PSA between 4 and 10 ng/ml
by: Emerson P. Gregorio, et al.
Published: (2007-04-01)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
by: Törnblom, M, et al.
Published: (2001)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
by: , DAHESIHDEWI, Andaru, et al.
Published: (2002)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
by: Sävblom, C, et al.
Published: (2009)

Geographic-Level Association of Contemporary Changes in Localized and Metastatic Prostate Cancer Incidence in the Era of Decreasing PSA Screening
by: Daniel X. Yang MD, et al.
Published: (2020-01-01)

Predictors of annual prostate-specific antigen (PSA) screening among black men: results from an urban community-based prostate cancer screening program
by: Marquita W. Lewis-Thames, et al.
Published: (2021-09-01)

Free PSA and prostate volume on the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2003-01-01)

Phage display screening identifies a prostate specific antigen (PSA)–/lo prostate cancer cell specific peptide to retard castration resistance of prostate cancer
by: Yi Sui, et al.
Published: (2021-03-01)

Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
by: Lilja, H
Published: (2001)

Clinical application of p2PSA and its derivatives (%p2PSA and Phi) in the diagnosis of prostate cancer
by: Weiwang Cai, et al.
Published: (2023-11-01)

Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators
by: Xiaomin Liu, et al.
Published: (2023-07-01)